Novel benzimidazole phosphonates as potential inhibitors of protein prenylation

Bioorganic & Medicinal Chemistry Letters
2019.0

Abstract

Benzimidazole carboxyphosphonates and bisphosphonates have been prepared and evaluated for their activity as inhibitors of protein prenylation or isoprenoid biosynthesis. The nature of the phosphonate head group was found to dictate enzyme specificity. The lead carboxyphosphonate inhibits geranylgeranyl transferase II while its corresponding bisphosphonate analogue potently inhibits farnesyl diphosphate synthase. The most active inhibitors effectively disrupted protein prenylation in human multiple myeloma cells.

Knowledge Graph

Similar Paper

Novel benzimidazole phosphonates as potential inhibitors of protein prenylation
Bioorganic & Medicinal Chemistry Letters 2019.0
Triazole-based inhibitors of geranylgeranyltransferase II
Bioorganic & Medicinal Chemistry Letters 2013.0
Bisphosphonates target multiple sites in both cis - and trans -prenyltransferases
Proceedings of the National Academy of Sciences 2007.0
Pyridinium-1-yl Bisphosphonates Are Potent Inhibitors of Farnesyl Diphosphate Synthase and Bone Resorption
Journal of Medicinal Chemistry 2005.0
Inhibition of Geranylgeranyl Diphosphate Synthase by Bisphosphonates and Diphosphates:  A Potential Route to New Bone Antiresorption and Antiparasitic Agents
Journal of Medicinal Chemistry 2002.0
Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis, Chiral High Performance Liquid Chromatographic Resolution and Enantiospecific Activity of a Potent New Geranylgeranyl Transferase Inhibitor, 2-Hydroxy-3-imidazo[1,2-a]pyridin-3-yl-2-phosphonopropionic Acid
Journal of Medicinal Chemistry 2010.0
Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site ‘capping’ phenyls
Bioorganic & Medicinal Chemistry 2012.0
Thienopyrimidine Bisphosphonate (ThPBP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase: Optimization and Characterization of the Mode of Inhibition
Journal of Medicinal Chemistry 2013.0
Isoprenoid Biosynthesis as a Drug Target:  Bisphosphonate Inhibition of Escherichia coli K12 Growth and Synergistic Effects of Fosmidomycin
Journal of Medicinal Chemistry 2006.0